DEFB108F: A Potential Drug Target and Biomarker (G100133128)

Target Name: DEFB108F

NCBI ID: G100133128

DEFB108F

Other Name(s): DEFB108P5 | Defensin beta 108F (pseudogene) | defensin beta 108F (pseudogene)

DEFB108F: A Potential Drug Target and Biomarker

DEFB108F is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in response to increased levels of thermal stress. One of the functions of HSPs is to help the body recover from thermal stress, and DEFB108F may be involved in this process.

Potential Drug Target

DEFB108F has been identified as a potential drug target because it is involved in a number of important cellular processes. It is a protein that is involved in the regulation of cell death, and it has been shown to play a role in the development of neurodegenerative diseases. In addition, DEFB108F is also involved in the regulation of cell growth and in the development of cancer.

One of the ways that DEFB108F may be involved in these processes is by helping to prevent the formation of neurodegenerate cells. neurodegenerate diseases, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and the development of characteristic symptoms. DEFB108F may be involved in the prevention of this by helping to regulate the formation of neurodegenerate cells.

Another potential mechanism by which DEFB108F may be involved in the development of neurodegenerative diseases is by contributing to the regulation of the immune response. neurodegenerate diseases are often associated with an imbalance in the immune system, and DEFB108F may be involved in the regulation of this process.

Biomarker

DEFB108F may also be a useful biomarker for the diagnosis and monitoring of neurodegenerative diseases. The levels of DEFB108F in certain neurodegenerate diseases have been shown to be decreased compared to healthy brain tissue. This suggests that DEFB108F may be a useful biomarker for the diagnosis and monitoring of neurodegenerative diseases.

Conclusion

In conclusion, DEFB108F is a protein that is expressed in various tissues of the body and is involved in a number of important cellular processes. It is potential drug target and biomarker for neurodegenerative diseases. Further research is needed to fully understand its role in these processes and its potential as a drug.

Protein Name: Defensin Beta 108F (pseudogene)

The "DEFB108F Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DEFB108F comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets